Orbimed Advisors - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 42 filers reported holding ASLAN PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2022$1,747,000
-20.8%
1,941,219
-1.5%
0.03%0.0%
Q4 2021$2,206,000
-37.1%
1,970,0000.0%0.03%
-28.2%
Q3 2021$3,507,000
-57.8%
1,970,000
-21.8%
0.04%
-53.6%
Q2 2021$8,316,000
-1.5%
2,520,0000.0%0.08%
+6.3%
Q1 2021$8,442,0002,520,0000.08%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 568,182$1,068,1810.12%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders